Production (Stage)
COSCIENS Biopharma Inc.
CSCI
$3.68
$0.113.08%
NASDAQ
| 03/31/2025 | 12/31/2024 | 06/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -53.43% | 145.48% | -34.09% | -34.09% | -36.54% |
| Total Receivables | 503.57% | 752.07% | 38.69% | 38.69% | -84.65% |
| Inventory | 3,735.94% | -32.88% | 3,184.95% | 3,184.95% | -71.81% |
| Prepaid Expenses | 11.27% | 1,998.77% | -99.85% | -99.85% | -33.23% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | 247.37% | -- | -- | -- |
| Total Current Assets | -34.75% | 112.84% | -27.64% | -27.64% | -38.48% |
|
|
|||||
| Total Current Assets | -34.75% | 112.84% | -27.64% | -27.64% | -38.48% |
| Net Property, Plant & Equipment | 3,833.21% | -5.83% | 4,239.25% | 4,239.25% | 9.27% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -100.00% | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -60.74% | -85.11% | 516.31% | 516.31% | 0.00% |
| Total Assets | -2.05% | 47.69% | 7.66% | 7.66% | -38.01% |
|
|
|||||
| Total Accounts Payable | 18.90% | 756.58% | -- | -- | -- |
| Total Accrued Expenses | -0.52% | 224.35% | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 64.29% | -9.36% | 180.69% | 180.69% | 14.93% |
| Total Finance Division Other Current Liabilities | 161.43% | -- | -7.17% | -7.17% | -87.57% |
| Total Other Current Liabilities | 161.43% | -- | -7.17% | -7.17% | -87.57% |
| Total Current Liabilities | 34.41% | 450.88% | 142.78% | 142.78% | -18.37% |
|
|
|||||
| Total Current Liabilities | 34.41% | 450.88% | 142.78% | 142.78% | -18.37% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 2,366.25% | 45.75% | 1,405.88% | 1,405.88% | 5.26% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -11.30% | -- | -4.55% | -4.55% | -0.55% |
| Total Liabilities | 11.56% | 708.45% | 36.85% | 36.85% | -6.24% |
|
|
|||||
| Common Stock & APIC | -92.33% | 66.35% | -92.50% | -92.50% | 0.00% |
| Retained Earnings | 96.09% | -378.01% | 100.43% | 100.43% | -5.26% |
| Treasury Stock & Other | -97.58% | -11.92% | -97.15% | -97.15% | 0.56% |
| Total Common Equity | -21.79% | -37.43% | -9.81% | -9.81% | -58.44% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -21.79% | -37.43% | -9.81% | -9.81% | -58.44% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -21.79% | -37.43% | -9.81% | -9.81% | -58.44% |
|
|
|||||